fda approved semaglutide compound ends shortage, closing the door on compounded Wegovy, Ozempic Compounded Semaglutide (GLP-1)

Growth signals are activating

Food and Drug Administration (FDA) expanded Wegovys approved uses to include reducing the risk of cardiovascular death, heart attack, and stroke in adults who are obese, overweight, or have established cardiovascular disease

Guidance for Industry: Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products-Chemistry, Manufacturing, and Controls Documentation [Internet] (accessed November 30, 2025) [Google Scholar] Ugwoke M., Agu R., Verbeke N., Kinget R

Physiol Rev 87(4):14091439 Campbell JE, Drucker DJ (2013) Pharmacology, physiology, and mechanisms of incretin hormone action